He is currently Professor of Molecular Cardiology at the UCL-Institute of Child Health, London, where he has been a principal investigator within the Molecular Medicine Unit at UCL-ICH since 1999. Paul provides advisory support on alliance development, outcomes-based contracting and social impact bond (SIB) commissioning, tendering and performance management. View the profiles of people named Paul Riley.
paul riley 77 higher market street, kearsley, bolton, lancashire paul riley collier close coppice side industrial estate, brownhills paul riley 13 glenhurst road, brentford paul riley 69 kitchen road wombwell, barnsley paul riley 5 gorseywell lane preston brook, runcorn The award recognises a landmark discovery in the field of basic cardiovascular science when his team found that Thymosin 4 could mobilise dormant cells from adult epicardium to form new blood vessels in the heart, a major step towards finding a DIY mechanism to repair injury following a heart attack.To investigate the potential of the epicardium as a source of multipotent cardiovascular progenitor cells in the adult heart capable of initiating neovascularisation and myocardial repair. An associate consultant with IPC since the beginning of 2018, Paul’s work has focused upon service provider alliance development and outcomes-based commissioning. Paul’s particular strengths lie in strategy development, service review and improvement, value chain design, ... Institute of Public Care is a centre of Oxford Brookes University, Headington Campus, Gipsy Lane, Oxford, OX3 0BP.
In 2008, Professor Riley was awarded the Outstanding Achievement Award of the European Society of Cardiology (ESC) Council on Basic Sciences.
He has over 30 years’ experience across a range of sectors to improve outcomes, manage commercial risks, and reduce costs.
More recently this has included supporting Social Impact Bond commissioning from both service provider and commissioner perspectives.His most recent post prior to working with IPC was Executive Director, Strategic Development and Partnerships for an international children’s social care organisation.
Journal article.
Professor Riley's team are focusing on exploiting the full potential of activated epicardial cells (from the layer around the heart) to regenerate adult heart tissue, and on understanding how this potential might benefit patients suffering cardiovascular disease.
BHF Professor Paul Riley, who led the research at the University of Oxford's Department of Physiology, Anatomy and Genetics, said: 'We are trying to better understand how the heart develops, and ultimately what causes the heart defects that develop in the womb …
He is also director of a recently established BHF Oxbridge Centre for Regenerative Medicine. Paul Riley took up the Chair of Development and Cell Biology in the Department of Physiology, Anatomy and Genetics on 1st October 2011, having been awarded a British Heart Foundation Personal Chair of Regenerative Medicine to support this position. During the last 15 years he has undertaken a range of advisory assignments at local, regional and national level for government, service provider and social investor clients. The application of epicardial cell biology to treatment of cardiovascular injury originates from the epicardium’s developmental plasticity and from the ability to reactivate these properties in the adult heart.
and Riley PR., (2018), Development (Cambridge, England), 145 He is an associate consultant with the Institute of Public Care, as well as undertaking assignments in his own right. Join Facebook to connect with Paul Riley and others you may know. Paul Riley Associate Consultant. The ontogeny, activation and function of the epicardium during heart development and regeneration. About.